Summary of Purpose
The purpose of this study in to evaluate safety, tolerability, pharmacokinetics of JPI-289 in healthy male subjects.Read More →
The following dates are available for this trial. Trial information last updated on 23 June 2016.
|1 Nov 2013||4 Nov 2013||1 Aug 2014||1 Sep 2014||1 Sep 2014||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Allocation: Randomized
- Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
- Endpoint: Pharmacokinetics/Dynamics Study
- Intervention: Parallel Assignment
- Hyeong-Seok Lim, M.D.,Ph.D.